Sep

18

2021

What agents are FDA-approved for prevention of pain crises in patients with sickle cell disease (SCD)?

By William Aird

A

What agents are FDA-approved for prevention of pain crises in patients with sickle cell disease (SCD)?

Hydroxyurea (since 1998), L-glutamine, crizanlizumab, voxelotor

Posted on September 18, 2021

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.